Inorganic Ions, Osmoregulation and DNA Probes for Genetic Screening Revision Notes | A Level AQA Biology
A DNA probe is a short, single-stranded piece of DNA complementary to a target allele and labelled with a fluorescent dye. Free notes and 14 questions answered.
Updated 5 Sept 2026 · Revise Right Team
Inorganic Ions, Osmoregulation and DNA Probes for Genetic Screening is part of Gene technologies allow the study and alteration of gene function allowing a better understanding of organism function and the design of new... in A Level AQA Biology.
9 min
Reading time
20
Lessons in this topic
A Level AQA
Pathway
Reviewed by Revise Right
Content review
What this lesson covers
A DNA probe is a short, single-stranded piece of DNA complementary to a target allele and labelled with a fluorescent dye. Free notes and 14 questions answered.
Explain the role of inorganic ions in the cytoplasm and body fluids of organisms, including their varying concentrations
Describe osmoregulation as the control of water potential of the blood
Explain how labelled DNA probes and DNA hybridisation are used to locate specific alleles of genes
Evaluate information relating to screening individuals for genetically determined conditions and drug responses
Revise Right Mocks '26
AQA A-Level Biology mock draft, 26–31 Oct. Draft coverage: Biology 7402/1 · Paper 1. Reviewed for an original-practice sitting; check student availability before registering. Marking and results will follow later, after separate approval. Eligible new accounts receive a five-day Pro trial when signup email verification completes. Previous trials keep their original expiry. After expiry, new papers need Pro unless you have an explicitly confirmed free sitting offer for this event. That offer adds no Pro time or AI learning. Saved attempts and released results remain readable. No card or automatic charge.
Use this lesson to stay inside Gene technologies allow the study and alteration of gene function allowing a better understanding of organism function and the design of new... while connecting the detail back to the wider The control of gene expression (A-level only) topic.
DNA probe: A short, single-stranded sequence of DNA that is complementary to a target allele, labelled with a fluorescent or radioactive marker so its binding can be detected.
DNA hybridisation: The process by which a single-stranded DNA probe forms hydrogen bonds with a complementary single-stranded target DNA sequence, used to locate specific alleles.
Osmoregulation: The physiological control of the water potential of the blood and body fluids, maintaining homeostatic balance between water gain and water loss.
Genetic screening: The testing of individuals or populations for the presence of specific alleles associated with inherited conditions or variable drug responses.
Revision notes
Read the core explanations from Inorganic Ions, Osmoregulation and DNA Probes for Genetic Screening before testing yourself from memory.
1. Setting the Scene: Why Ions, Water, and DNA Probes Belong Together
You have spent the last two parts of this series building up genetic fingerprinting from the ground up. Now, in Part 3, the focus shifts to three interconnected ideas: the inorganic ions dissolved in body fluids, the water potential those fluids must maintain, and the DNA probe technology that lets scientists read specific alleles from a genome. Together, these threads feed directly into genetic screening — one of the most ethically charged applications in modern biology.
Each of these topics appears deceptively simple on its own. The challenge — and the exam opportunity — is connecting them precisely and using the correct terminology under pressure. That is exactly what this lesson trains you to do.
2. Inorganic Ions and Osmoregulation: Foundation Concepts for Genetic Screening
Picture the cytoplasm of a cell and the plasma of blood as a carefully managed solution. Dissolved within that solution are inorganic ions — charged particles such as sodium ($\text{Na}^+$), potassium ($\text{K}^+$), chloride ($\text{Cl}^-$), hydrogen carbonate ($\text{HCO}_3^-$), calcium ($\text{Ca}^{2+}$), and hydrogen ($\text{H}^+$). The AQA specification states clearly that some of these ions occur in high concentrations and others in very low concentrations, and that distinction matters enormously for function.
Consider sodium and potassium as a paired example. Sodium ions are maintained at high concentration outside cells (in the blood plasma and tissue fluid) but at low concentration inside the cytoplasm. Potassium ions show the reverse pattern — high inside, low outside. This electrochemical gradient is not accidental; it is actively maintained by the sodium–potassium pump and is essential for generating nerve impulses and muscle contractions.
Hydrogen ions ($\text{H}^+$) occur at very low concentrations in blood plasma — a pH of 7.4 corresponds to a hydrogen ion concentration of roughly $4 \times 10^{-8}$ mol dm$^{-3}$. Even tiny shifts in this concentration alter enzyme activity and protein conformation. Calcium ions ($\text{Ca}^{2+}$) are present at low cytoplasmic concentrations but act as second messengers when released in pulses, triggering muscle contraction and exocytosis. The key principle is that concentration is not arbitrary — it is precisely regulated because function depends on it.
$\text{Na}^+$ — high in plasma, low in cytoplasm; maintains resting membrane potential
$\text{K}^+$ — high in cytoplasm, low in plasma; essential for repolarisation of neurones
$\text{Ca}^{2+}$ — very low in cytoplasm at rest; released as a signalling ion
$\text{H}^+$ — extremely low in blood (pH 7.4); tightly buffered to protect enzyme function
$\text{Cl}^-$ — high in plasma; contributes to osmotic balance and charge neutrality
$\text{HCO}_3^-$ — major buffer in blood; transports $\text{CO}_2$ from tissues to lungs
This brings us directly to the next concept. Because inorganic ions are solutes, their concentration determines the water potential of the fluid they are dissolved in. Regulating ion concentration and regulating water potential are therefore two sides of the same coin.
3. Osmoregulation: Controlling Blood Water Potential
Osmoregulation is defined by AQA as the control of the water potential of the blood. Water potential ($\Psi$) is a measure of the tendency of water molecules to move by osmosis — the more solutes dissolved, the lower (more negative) the water potential. If blood water potential falls too low, water leaves cells by osmosis and they shrink. If it rises too high, water enters cells and they may burst. Either extreme is lethal.
The kidneys are the primary osmoregulatory organs. When blood water potential falls — for example after sweating heavily or eating a salty meal — osmoreceptors in the hypothalamus detect the change. The posterior pituitary gland releases more antidiuretic hormone (ADH). ADH increases the permeability of the collecting duct and distal convoluted tubule to water, so more water is reabsorbed by osmosis into the blood. The result is a small volume of concentrated urine and a restored blood water potential.
When blood water potential rises — after drinking a large volume of water — ADH secretion falls. The collecting duct becomes less permeable to water, less water is reabsorbed, and a large volume of dilute urine is produced. This negative feedback loop keeps blood water potential within a narrow, safe range.
Notice how inorganic ions feed directly into this story. A rise in plasma sodium concentration lowers blood water potential, triggering the same ADH response described above. Osmoregulation and ion regulation are therefore inseparable in practice, even though the specification treats them as distinct points.
4. DNA Probes and Hybridisation: Reading the Genome
Now the lesson pivots to gene technology. Suppose you want to know whether a particular individual carries a specific allele — perhaps the allele associated with cystic fibrosis, or a variant that affects how they metabolise a drug. You cannot see alleles with the naked eye. You need a molecular tool that can find a specific sequence among the three billion base pairs of the human genome. That tool is a labelled DNA probe used in DNA hybridisation.
A DNA probe is a short, single-stranded piece of DNA whose sequence is complementary to the target allele you want to detect. It is labelled — either with a fluorescent dye or a radioactive isotope — so that wherever it binds, you can see it. The process of the probe binding to its complementary target sequence is called DNA hybridisation, and it works because complementary bases form hydrogen bonds: adenine pairs with thymine, and guanine pairs with cytosine.
Worked example: How DNA Hybridisation Locates a Specific Allele
Describe the sequence of steps by which a labelled DNA probe is used to determine whether a patient carries a specific disease allele.
DNA is extracted from the patient's cells (e.g. white blood cells). The double-stranded DNA is denatured — heated or treated with alkali — to separate the two strands, producing single-stranded DNA. — Single-stranded DNA is required because the probe must be able to access and bind to the complementary base sequence. Double-stranded DNA would block probe access.
The single-stranded DNA fragments are fixed to a nylon membrane (in Southern blotting) or spotted onto a DNA microarray chip, so they cannot wash away during the hybridisation step. — Immobilising the target DNA ensures that any probe binding is stable and detectable. Microarrays allow thousands of alleles to be screened simultaneously.
A solution containing the labelled probe — a short, single-stranded DNA sequence complementary to the target allele — is washed over the membrane or microarray under controlled temperature and salt conditions. — Temperature and salt concentration are carefully controlled to ensure the probe only binds to sequences that are a close match. Too high a temperature and the probe will not bind at all; too low and it may bind to non-complementary sequences (non-specific binding).
Where the probe sequence is complementary to the target allele, hydrogen bonds form between the base pairs (A–T and G–C), and the probe hybridises (binds) to the target strand. — This is the key step. The specificity of base pairing means the probe will only hybridise to its exact complementary sequence — this is what makes the technique allele-specific.
Excess, unbound probe is washed off the membrane or microarray, leaving only probe molecules that have successfully hybridised to the target sequence. — This washing step is critical for reducing background signal. Any probe that has not formed stable hydrogen bonds with a complementary sequence is removed.
If a fluorescent probe was used, the membrane or microarray is viewed under UV light — a glowing spot indicates the target allele is present. If a radioactive probe was used, X-ray film (autoradiography) is exposed to the membrane and a dark band appears where the probe has bound. — The presence of a signal confirms that the patient's DNA contains the target allele. Absence of signal means the allele was not detected. A positive result does not automatically mean the individual will develop a condition — they may be a carrier (heterozygous).
Answer: A labelled DNA probe hybridises to its complementary target allele via hydrogen bonding after the patient's DNA has been denatured to single strands. Detection of the fluorescent or radioactive label confirms the presence of the allele.
One detail that trips students up is the difference between detecting the allele and diagnosing the condition. A probe tells you whether the allele is present — it does not tell you whether the individual will be affected. For a recessive condition such as cystic fibrosis, a person could carry one copy of the allele (heterozygous carrier) and show no symptoms. Interpreting probe results always requires knowledge of the inheritance pattern of the condition.
5. Genetic Screening: Applications and Evaluation
DNA probes and hybridisation are the technical foundation of genetic screening — the testing of individuals or populations for specific alleles. Screening programmes exist for a range of purposes: identifying carriers of inherited conditions before they have children, diagnosing conditions in newborns (neonatal screening), testing embryos produced by IVF (preimplantation genetic diagnosis), and predicting how a patient will respond to a particular drug (pharmacogenomics).
The AQA specification requires you to evaluate information about screening. That means you need to be able to weigh up evidence, consider both benefits and limitations, and reach a reasoned conclusion. The table below structures the key arguments you should be able to deploy.
Aspect
Arguments in Favour
Arguments Against / Limitations
Screening for inherited conditions (e.g. BRCA1 allele for breast cancer risk)
Allows early intervention, increased monitoring, or preventive surgery; reduces mortality; informs reproductive decisions
Result is probabilistic, not certain — carrying the allele does not guarantee the condition develops; may cause psychological distress; risk of insurance or employment discrimination
Neonatal screening (e.g. PKU test)
Early dietary intervention prevents irreversible brain damage; cost-effective at population level
Parental anxiety from false positives; some conditions screened for have no current treatment
Preimplantation genetic diagnosis (PGD)
Prevents transmission of serious inherited conditions to offspring; avoids termination of established pregnancies
Raises ethical concerns about 'designer babies'; low success rate of IVF; limited to families already using assisted reproduction
Pharmacogenomics (drug response screening)
Allows personalised prescribing — correct drug and dose first time; reduces adverse drug reactions; more efficient use of NHS resources
Not all drug-response alleles are yet characterised; testing adds cost and time before treatment begins; may delay urgent treatment
When an exam question asks you to evaluate, the mark scheme rewards a structured response: state a benefit with a specific example, state a limitation with a specific example, and then reach a conclusion that weighs the two sides. Vague statements such as 'it could be good or bad' will not score evaluation marks. You need to commit to a reasoned judgement.
Pharmacogenomics deserves particular attention because it links gene technology directly to clinical practice. Different alleles of genes encoding drug-metabolising enzymes (such as cytochrome P450 variants) mean that the same drug dose can be therapeutic in one patient, ineffective in another, and toxic in a third. Screening for these alleles before prescribing allows doctors to select the right drug and dose from the outset, reducing adverse reactions and improving outcomes.
6. Exam Technique: Securing Every Mark
The four specification points in this lesson each carry distinct command-word demands in exam questions. Getting the command word right is the difference between a full-mark response and one that misses the point entirely.
For 'describe' questions about osmoregulation or DNA hybridisation, sequence matters. Write what happens first, then what happens next, using connective words such as 'this causes', 'as a result', and 'consequently'. Do not explain why at this stage — save that for 'explain' questions. For 'explain' questions, every observation must be followed by a mechanistic reason using 'because' or 'therefore'.
For 'evaluate' questions on genetic screening, the mark scheme almost always requires: at least one developed benefit, at least one developed limitation, and a conclusion. A conclusion that restates the question ('so screening can be useful') will not score the evaluation mark. Your conclusion must weigh the specific evidence you have presented and commit to a judgement.
Across all four specification points in this lesson — inorganic ions, osmoregulation, DNA probes, and genetic screening — the unifying theme is precision: precise ion concentrations maintain water potential; precise base complementarity makes probes allele-specific; and precise evaluation of evidence is what earns marks in extended-response questions. Carry that precision into the exam and you will be well placed to access the top mark bands.
Sources and content standards
Published by Revise Right. Use the official specification reference to check the requirements for your course. Content updated: 2026-09-05.
A DNA probe is a short, single-stranded piece of DNA with a base sequence complementary to a target allele, labelled with a fluorescent dye or a radioactive isotope. When it binds to its complementary sequence by hydrogen bonding, the label shows where the target allele is, so probes can detect specific alleles.
How are DNA probes used to find a specific allele?
The patient's DNA is extracted and denatured into single strands, then fixed to a membrane or microarray. A labelled probe is added and hybridises by hydrogen bonding to any complementary target sequence. Unbound probe is washed away, and a glowing spot under UV light or a dark band on X-ray film shows the allele is present.
What is pharmacogenomics?
Pharmacogenomics is screening patients for alleles that affect their response to drugs, such as variants of cytochrome P450 drug-metabolising enzymes. The same dose can be therapeutic in one patient, ineffective in another and toxic in a third, so screening lets doctors choose the right drug and dose first time, reducing adverse reactions.
What is a DNA microarray?
A DNA microarray is a chip onto which single-stranded DNA is spotted so it cannot wash away during hybridisation. Labelled probes then bind where sequences are complementary, allowing thousands of alleles to be screened at the same time.
What are the advantages and disadvantages of genetic screening?
Screening for alleles such as BRCA1 allows early intervention, increased monitoring or preventive surgery and informs reproductive decisions. However, results are probabilistic, so carrying an allele does not guarantee the condition develops; results may cause psychological distress and risk insurance or employment discrimination, and a positive result may only mean the person is a carrier.
What is genetic screening used for?
Genetic screening tests individuals for specific alleles. It is used to identify carriers of inherited conditions before they have children, to screen newborns for conditions such as PKU, to test IVF embryos by preimplantation genetic diagnosis, and to predict how a patient will respond to a particular drug.
Why is DNA denatured before adding a probe?
DNA is denatured, by heating or treating with alkali, to separate the two strands into single-stranded DNA. The probe can then access and bind to its complementary base sequence; double-stranded DNA would block probe access.
How are DNA probes labelled?
DNA probes are labelled with either a fluorescent dye or a radioactive isotope. A fluorescent probe shows as a glowing spot under UV light, while a radioactive probe is detected by exposing X-ray film to give a dark band where it has bound.
Why is unbound probe washed away?
Unbound probe is washed off so that only probe molecules that have formed stable hydrogen bonds with a complementary sequence remain. This reduces the background signal, so a detected signal confirms the target allele is present.
Does detecting a disease allele mean someone has the condition?
Detecting an allele with a DNA probe shows the allele is present, not that the person will be affected. For a recessive condition such as cystic fibrosis, a heterozygous carrier has one copy and no symptoms, so results must be interpreted using the inheritance pattern.
What are the benefits and drawbacks of neonatal screening?
Neonatal screening, such as the PKU test, allows early dietary intervention that prevents irreversible brain damage and is cost-effective at population level. Limitations include parental anxiety from false positives and the fact that some conditions screened for have no current treatment.
What is preimplantation genetic diagnosis?
Preimplantation genetic diagnosis (PGD) is testing embryos produced by IVF for specific alleles before implantation. It can prevent serious inherited conditions being passed on without terminating established pregnancies, but raises concerns about 'designer babies', and IVF has a low success rate.
Why do people respond differently to the same drug dose?
Different alleles of genes encoding drug-metabolising enzymes, such as cytochrome P450 variants, mean the same dose can be therapeutic in one patient, ineffective in another and toxic in a third. Screening for these alleles allows the right drug and dose from the outset.
Why do temperature and salt matter in DNA hybridisation?
Temperature and salt concentration are controlled so the probe binds only to closely matching sequences. If the temperature is too high the probe will not bind at all; if too low, it may bind to non-complementary sequences, called non-specific binding.